Literature DB >> 15514029

Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.

Alon Chen1, Marilyn Perrin, Bhawanjit Brar, Chien Li, Pauline Jamieson, Mike Digruccio, Kathy Lewis, Wylie Vale.   

Abstract

Effects of the corticotropin-releasing factor (CRF) family of peptides are mediated through activation of two receptors, CRF receptor (CRFR) 1 and CRFR2. Based on the homology between known mammalian CRFR genes, we have isolated a cDNA encoding the mouse CRFR2alpha (mCRFR2alpha) ortholog from brain. The isolated cDNA encodes a 411-amino acid protein with high identity to the rat (approximately 97%) and human (approximately 93%) receptors. Central and peripheral expression of mCRFR2alpha, determined by RT-PCR followed by Southern hybridization, revealed that mCRFR2alpha is restricted mainly to brain structures, with highest levels in the hypothalamus and olfactory bulb. In situ hybridization showed mCRFR2alpha localization in discrete brain regions, including the lateral septum and the ventromedial hypothalamus, whereas mCRFR2beta is found only in the choroid plexus. Binding and signaling of CRF-related ligands was studied using COS-M6 or HEK293T cells transiently transfected with mCRFR2alpha. Urocortins (Ucns) show different affinities for binding to mCRFR2alpha: Ucn 3 binds mCRFR2alpha with approximately 11-fold lower affinity than Ucn 2, which displays an affinity similar to Ucn 1 (approximately 1 nm). Cyclase activation, determined by intracellular cAMP accumulation and cAMP response element-luciferase activity, showed no differences between CRFR2alpha and CRFR2beta in response to stimulation by Ucn 1, Ucn 2, and Ucn 3. Interestingly, Ucn 3 was less efficacious than Ucn 1 or Ucn 2 in activating MAPK (ERK1/2-p44/p42) via CRFR2alpha, but all three Ucns showed equivalent efficacy for activating MAPK through mCRFR2beta. We found a significant reduction in hypothalamic mCRFR2alpha mRNA levels after acute and chronic restraint stress in mice. Hypothalamic mCRFR2alpha gene transcription in mice was inhibited by glucocorticoid administration and elevated by adrenalectomy. In addition, we demonstrated that the mCRFR2alpha gene is increased in the hypothalamus of the CRFR1-null compared with wild type mice. The predicted mCRFR2alpha promoter region was isolated and fused to a luciferase reporter gene and found to be decreased by glucocorticoids in a dose and time-dependent manner when transfected into CATH.a cells. Computer analysis revealed the presence of 23 putative half-palindromic glucocorticoid response element sequences within 2.4 kb of the mCRFR2alpha 5' flanking region. Elucidation of the structure and processing of the mCRFR2 gene and examination of the mCRFR2alpha gene regulation in various conditions will enable better understanding of the involvement of this receptor in the central response to stress in normal and transgenic mice models.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15514029     DOI: 10.1210/me.2004-0300

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  42 in total

1.  Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.

Authors:  Guillaume Gourcerol; S Vincent Wu; Pu-Qing Yuan; Hung Pham; Marcel Miampamba; Muriel Larauche; Paul Sanders; Tomofumi Amano; Agata Mulak; Eunok Im; Charalabos Pothoulakis; Jean Rivier; Yvette Taché; Mulugeta Million
Journal:  Gastroenterology       Date:  2011-01-26       Impact factor: 22.682

2.  Effects of social isolation on mRNA expression for corticotrophin-releasing hormone receptors in prairie voles.

Authors:  Hossein Pournajafi-Nazarloo; Leila Partoo; Jason Yee; Jennifer Stevenson; Lisa Sanzenbacher; William Kenkel; Seyed Ramezan Mohsenpour; Kozo Hashimoto; C Sue Carter
Journal:  Psychoneuroendocrinology       Date:  2010-11-20       Impact factor: 4.905

3.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

4.  Genetic approach for intracerebroventricular delivery.

Authors:  Limor Regev; Eli Ezrielev; Eran Gershon; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

5.  Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.

Authors:  Evan N Graf; Michael A Hoks; Jean Baumgardner; Jose Sierra; Oliver Vranjkovic; Colin Bohr; David A Baker; John R Mantsch
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

6.  Effects of sleep deprivation on behaviors and abnormal hippocampal BDNF/miR-10B expression in rats with chronic stress depression.

Authors:  Yuxue Jiang; Jinfu Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 7.  Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model.

Authors:  Rita J Valentino; Debra Bangasser; Elisabeth J Van Bockstaele
Journal:  Mol Pharmacol       Date:  2012-12-13       Impact factor: 4.436

8.  The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.

Authors:  B Lu; Y Diz-Chaves; D Markovic; A Contarino; L Penicaud; F Fanelli; S Clark; H Lehnert; D Cota; D K Grammatopoulos; A Tabarin
Journal:  Int J Obes (Lond)       Date:  2014-09-05       Impact factor: 5.095

Review 9.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 10.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.